Medisch Kabinet Dr. Luc Cavens, neurochirurg
0671.736.975 · rovalta.com · 28/09/2026
ACTIVE
Medisch Kabinet Dr. Luc Cavens, neurochirurg
Financial year 2025 · Closed on 31/12/2025
Net result44 k €-10,8 %over 1 year
Gross margin148 k €-4,7 %over 1 year
Equity423,8 k €+11,6 %over 1 year
Overview
Identity
Source · BCE/KBOMedisch Kabinet Dr. Luc Cavens, neurochirurg is a Private company with limited liability incorporated in 2017. Its registered office is in Antwerpen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0671.736.975
- Incorporation
- 22/02/2017
- Legal form
- Private company with limited liability
- Registered office
- Lodewijk Van Sullstraat 46
2600 Antwerpen · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 148 k € | -4.7% | 155,3 k € | +19.7% | 129,8 k € | +172% | 47,7 k € | -58.4% | 114,8 k € |
| EBITDA | 143,7 k € | -6.7% | 154 k € | +19.5% | 128,8 k € | +178% | 46,4 k € | -59.1% | 113,5 k € |
| Operating result | 61,8 k € | -11.6% | 69,9 k € | +60.0% | 43,7 k € | +220% | -36,3 k € | -214% | 32 k € |
| Net result | 44 k € | -10.8% | 49,3 k € | +23.0% | 40,1 k € | +209% | -36,9 k € | -274% | 21,1 k € |
| Balance sheet | |||||||||
| Equity | 423,8 k € | +11.6% | 379,8 k € | +14.9% | 330,5 k € | +13.8% | 290,4 k € | -11.3% | 327,2 k € |
| Total assets | 559,2 k € | +5.5% | 529,9 k € | -0.4% | 532 k € | -8.6% | 581,9 k € | -11.5% | 657,6 k € |
| Cash | 460,3 k € | +66.3% | 276,8 k € | +14.0% | 242,8 k € | +13.4% | 214,1 k € | +13.8% | 188 k € |
| Debts | 135,4 k € | -9.8% | 150,2 k € | -25.5% | 201,5 k € | -30.9% | 291,5 k € | -11.8% | 330,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Luc CAVENS | DirectorManagerended |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 03/08/2026 | 26/08/2025 | 22/08/2024 | 14/07/2023 | 13/07/2022 | 26/08/2021 |
| General meeting | 18/06/2026 | 19/06/2025 | 31/07/2024 | 15/06/2023 | 16/06/2022 | 29/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 18/06/2026 | 03/08/2026 | Dutch | |
| Micro model | 31/12/2024 | 19/06/2025 | 26/08/2025 | Dutch | |
| Micro model | 31/12/2023 | 31/07/2024 | 22/08/2024 | Dutch | |
| Micro model | 31/12/2022 | 15/06/2023 | 14/07/2023 | Dutch | |
| Micro model | 31/12/2021 | 16/06/2022 | 13/07/2022 | Dutch | |
| Micro model | 31/12/2020 | 29/07/2021 | 26/08/2021 | Dutch | |
| Micro model | 31/12/2019 | 18/06/2020 | 17/07/2020 | Dutch | |
| Micro model | 31/12/2018 | 20/06/2019 | 11/09/2019 | Dutch | |
| Micro model | 31/12/2017 | 21/06/2018 | 20/07/2018 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
Luc CAVENS | DirectorManagerended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other24/02/2017RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings9 filings
2017201820192020202120222023202420252026
Medisch Kabinet Dr. Luc Cavens, neurochirurg
Lodewijk Van Sullstraat 46, 2600 Berchem (Antwerp)
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Lodewijk Van Sullstraat 46, 2600 Berchem (Antwerp)Current | accounts 2021 → 2025 | Accounts 2025 · 2026-00387638 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Medisch Kabinet Dr. Luc Cavens, neurochirurgCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00387638 |
Events
- 2025Annual accounts 202544 k €↓
- 2024Annual accounts 202449,3 k €↑
- 2023Annual accounts 202340,1 k €↑
- 2022Annual accounts 2022-36,9 k €↓
- 2021Annual accounts 202121,1 k €↓
- 2020Annual accounts 202024,8 k €↓
- 2019Annual accounts 201970,6 k €↓
- 2018Annual accounts 201876,2 k €↓
- 2017Annual accounts 2017122 k €
- 22/02/2017IncorporationPrivate company with limited liability